Key result
Low genetic testing access and limited awareness remain linked to delayed SMA diagnosis and treatment.
Why the study?
Delayed diagnosis of spinal muscular atrophy remains a common issue worldwide, particularly in regions with unequal medical resources.
Case Report (n=5)
Delayed diagnosis of SMA remains a common issue due to limited awareness and unequal medical resources.
Supports heightened SMA suspicion and testing access; leaves open effective strategies to reduce diagnostic delays in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) conducted a case report in Spinal muscular atrophy (n=5). Delayed diagnosis and genetic testing was evaluated. Delayed diagnosis and delayed initiation of treatment for spinal muscular atrophy remain common issues due to limited awareness, low accessibility of genetic testing, and uneven medical resources.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: